As pharmaceutical manufacturers face increasing pressure to maintain production continuity, ensure regulatory compliance, and manage ageing equipment, the traditional approach to spare parts management is being challenged. Long OEM lead times, compon... Read more
As drug development becomes increasingly complex, early-phase clinical trials are taking on a far more strategic role than simply establishing safety. Sponsors are now expected to generate meaningful evidence that informs dose selecti... Read more
The promise of precision oncology depends not only on scientific innovation but also on successful implementation in routine clinical practice. Drawing on real-world data from community oncology settings, Andrew Osterland, PharmD, MS, Research Scient... Read more
As real-world evidence assumes a growing role in oncology research, regulatory evaluation, and clinical decision-making, the quality of underlying data has never been more important. Sarah Spark, MHA, MBA, Director of Clinical Data Quality at Ontada,... Read more
Senior secured term loan of up to CHF 250 million with a 5‑year maturity at a fixed 7% interest rate First tranche will fully refinance the existing New Money Facility, maturing in May 2027 Eliminates near‑term debt maturities and strengthens b... Read more
Q1 2026 Group performance Comparable order intake growth 6% Group sales of EUR 3.9 billion, reflecting 4% increase in comparable sales Income from operations increased to EUR 241 million Adjusted EBITA margin increased 40 basis points t... Read more
AGC Biologics, your friendly CDMO expert, was selected by Teikoku Seiyaku Co., Ltd., a leader in transdermal drug delivery, to provide microbial contract development and manufacturing services for KTP-001, a recombinant human matrix metalloproteina... Read more
LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company developing one-of-a-kind PD-1/VEGFR2 dual-paratopic antibodies, reinforcing a growing strategic ... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
